U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H12O7
Molecular Weight 304.2516
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TAXIFOLIN

SMILES

O[C@@H]1[C@H](OC2=C(C1=O)C(O)=CC(O)=C2)C3=CC(O)=C(O)C=C3

InChI

InChIKey=CXQWRCVTCMQVQX-LSDHHAIUSA-N
InChI=1S/C15H12O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,14-19,21H/t14-,15+/m0/s1

HIDE SMILES / InChI

Description

Dihydroquercetin (also known as taxifolin) is a flavonoid found in grapes, citrus fruits, onions, green tea, olive oil, and several herbs (such as milk thistle). Besides its antitumor, hepatoprotective, and anti-inflammatory activities, it is a potent antioxidant, which may contribute to its cardiovascular and neuroprotective properties. The drug was tested in vitro against cancer cells and in vivo, in preclinical models of liver diseases and cardiovascular diseases. The possible mechanism of actions involves the induction of phase II detoxifying enzymes and the suppression of cytochrome P450-dependent monooxygenases, apoptosis and disruption of cancer cell cycle progression.

Approval Year

Unknown
139594
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Basic research
Unknown

Approved Use

Unknown
Primary
Preclinical
Unknown

Approved Use

Unknown
Primary
Preclinical
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Inhibition of HEWL fibril formation by taxifolin: Mechanism of action.
2017
Patents

Patents

EP2825163 A1
2
US20130237712 A1
2
US20130267477 A1
2

Sample Use Guides

In Vivo Use Guide
In a preclinical study, rats with hepatitis were given 100 mg/kg dihydroquercetin s.c. for 4 days.
Route of Administration: Other
In Vitro Use Guide
in a MTT cytotoxicity assay, HCT116 cells (1*10(4) cells per well) were plated onto 96-well plates, incubated at 37C for 24 h, and the cells were treated with various concentrations of dihydroquercetin (3.9-250 uM). After 24 h, 10 ml of CCK-8 solution was added to the wells, and incubation continued for another 3 h.
Name Type Language
TAXIFOLIN
Common Name English
(+)-TAXIFOLIN
Common Name English
(+)-TAXIFOLIN (CONSTITUENT OF MILK THISTLE) [DSC]
Common Name English
2,3-DIHYDROQUERCETIN
Common Name English
3,5,7,3',4'-PENTAHYDROXYFLAVANONE
Systematic Name English
4H-1-BENZOPYRAN-4-ONE, 2-(3,4-DIHYDROXYPHENYL)-2,3-DIHYDRO-3,5,7-TRIHYDROXY-, (2R-TRANS)-
Systematic Name English
(+)-DIHYDROQUERCETIN
Common Name English
LAVITOL
Brand Name English
DIQUERTIN
Common Name English
FLAMENA D
Common Name English
DIHYDROQUERCETIN
INCI   WHO-DD  
INCI  
Official Name English
Dihydroquercetin [WHO-DD]
Common Name English
DIHYDROQUERCETIN [INCI]
Common Name English
DISTYLIN
Common Name English
FLAMENA
Common Name English
DIHYDROQUERCETIN, (+)-(2R,3R)-
Common Name English
(2R,3R)-(+)-TAXIFOLIN
Common Name English
(2R,3R)-3,3',4',5,7-PENTAHYDROXYFLAVANONE
Systematic Name English
TAXIFOLIOL
Common Name English
4H-1-BENZOPYRAN-4-ONE, 2-(3,4-DIHYDROXYPHENYL)-2,3-DIHYDRO-3,5,7-TRIHYDROXY-, (2R,3R)-
Systematic Name English
(+)-(2R,3R)-DIHYDROQUERCETIN
Common Name English
(+)-TAXIFOLIN (CONSTITUENT OF MARITIME PINE) [DSC]
Common Name English
(2R,3R)-DIHYDROQUERCETIN
Common Name English
FLAVANONE, 3,3',4',5,7-PENTAHYDROXY-
Systematic Name English
Classification Tree Code System Code
DSLD 3966 (Number of products:3)
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
Code System Code Type Description
CAS
480-18-2
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
SMS_ID
100000176866
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
ECHA (EC/EINECS)
207-543-4
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
MESH
C003377
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
GRAS Notification (GRN No.)
826
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
GRAS Notification (GRN No.)
916
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
PUBCHEM
439533
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
WIKIPEDIA
Taxifolin
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
EPA CompTox
DTXSID8022450
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
CHEBI
17948
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
DRUG BANK
DB02224
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
FDA UNII
9SOB9E3987
Created by admin on Sat Dec 16 01:32:40 GMT 2023 , Edited by admin on Sat Dec 16 01:32:40 GMT 2023
PRIMARY
SUBSTANCE RECORD
Structure of TAXIFOLIN
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966